| Name | Walgreens #13081 |
|---|---|
| Organization Name | Walgreen Co |
| Location | 399 Washington St, Newton, Massachusetts 02458 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Phone | (617) 658-6421 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
New research from The Scripps Research Institute may give scientists a chance to target tumors before they metastasize.
Cedars-Sinai Medical Center has been selected as one of the top work environments for technology specialists in the United States by Computerworld, a leading national publication devoted to information technology. The award recognizes dynamic work environments in which IT professionals support new technologies and contribute to projects that are critical to the business goals of an organization.
A combination of the kinase-inhibitor drug cabozantinib and the immunotherapy drug nivolumab can make curative surgery possible in some liver cancer patients who would normally not be considered surgery candidates.
Durata Therapeutics, Inc. today announced preliminary, top-line results for its DISCOVER 1 ("Dalbavancin for Infections of the Skin COmpared to Vancomycin at an Early Response") Phase 3 study of dalbavancin, which is under investigation for the treatment of acute bacterial skin and skin structure infections (ABSSSI) caused by susceptible gram-positive bacteria, including MRSA (methicillin resistant Staphylococcus aureus).
Investigators from Dartmouth's Norris Cotton Cancer Center led by James Moseley, PhD have found that the protein Pom1 possesses the ability to modify different sets of proteins to coordinate the processes of cell growth and division.
› Verified 2 days ago
| NPI Number | 1316256134 |
| Organization Name | WALGREEN CO |
| Doing Business As | WALGREENS #13081 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 399 Washington St, Newton, MA 02458 |
| Phone Number | 617-658-6421 |
News Archive
New research from The Scripps Research Institute may give scientists a chance to target tumors before they metastasize.
Cedars-Sinai Medical Center has been selected as one of the top work environments for technology specialists in the United States by Computerworld, a leading national publication devoted to information technology. The award recognizes dynamic work environments in which IT professionals support new technologies and contribute to projects that are critical to the business goals of an organization.
A combination of the kinase-inhibitor drug cabozantinib and the immunotherapy drug nivolumab can make curative surgery possible in some liver cancer patients who would normally not be considered surgery candidates.
Durata Therapeutics, Inc. today announced preliminary, top-line results for its DISCOVER 1 ("Dalbavancin for Infections of the Skin COmpared to Vancomycin at an Early Response") Phase 3 study of dalbavancin, which is under investigation for the treatment of acute bacterial skin and skin structure infections (ABSSSI) caused by susceptible gram-positive bacteria, including MRSA (methicillin resistant Staphylococcus aureus).
Investigators from Dartmouth's Norris Cotton Cancer Center led by James Moseley, PhD have found that the protein Pom1 possesses the ability to modify different sets of proteins to coordinate the processes of cell growth and division.
› Verified 2 days ago
News Archive
New research from The Scripps Research Institute may give scientists a chance to target tumors before they metastasize.
Cedars-Sinai Medical Center has been selected as one of the top work environments for technology specialists in the United States by Computerworld, a leading national publication devoted to information technology. The award recognizes dynamic work environments in which IT professionals support new technologies and contribute to projects that are critical to the business goals of an organization.
A combination of the kinase-inhibitor drug cabozantinib and the immunotherapy drug nivolumab can make curative surgery possible in some liver cancer patients who would normally not be considered surgery candidates.
Durata Therapeutics, Inc. today announced preliminary, top-line results for its DISCOVER 1 ("Dalbavancin for Infections of the Skin COmpared to Vancomycin at an Early Response") Phase 3 study of dalbavancin, which is under investigation for the treatment of acute bacterial skin and skin structure infections (ABSSSI) caused by susceptible gram-positive bacteria, including MRSA (methicillin resistant Staphylococcus aureus).
Investigators from Dartmouth's Norris Cotton Cancer Center led by James Moseley, PhD have found that the protein Pom1 possesses the ability to modify different sets of proteins to coordinate the processes of cell growth and division.
› Verified 2 days ago
Amber Specialty Pharmacy Type: Medicare Supplier Location: 300 Washington St, Newton, Massachusetts 02458 Phone: (888) 370-1724 | |
Cvs Pharmacy #01858 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 1199 1201 Center St, Newton, Massachusetts 02459 Phone: (617) 332-4900 | |
Cvs Pharmacy #06505 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 978 Boylston St, Newton, Massachusetts 02461 Phone: (617) 244-0821 | |
Newton Wellesley Eye Associates Pc Type: Medicare Supplier Location: 2000 Washington St, Newton, Massachusetts 02462 Phone: (617) 964-1050 | |
Next Step Bionics And Prosthetics, Type: Prosthetic/Orthotic Supplier Location: 57 Chapel St, Newton, Massachusetts 02458 Phone: (617) 581-6750 |